<DOC>
	<DOCNO>NCT02749422</DOCNO>
	<brief_summary>This randomize , single-blinded , control phase 1 study demonstrate feasibility explore neurophysiologic clinical effect repetitive transcranial magnetic stimulation ( TMS ) intervention epilepsy patient healthy control . The inclusion control group use see whether epilepsy patient , suffer high degree comorbid memory difficulty presumably entorhinal-hippocampal dysfunction , benefit TMS intervention benefit much healthy match population . Investigators also look functional connectivity hippocampus cortical region</brief_summary>
	<brief_title>fMRI Guided TMS Enhancement Associative Memory Networks</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Fluent English Righthanded Score least 26 30 Montreal Cognitive Assessment ( MOCA ) . Healthy subject match age , handedness , education compare epilepsy subject . Must able provide inform consent . Any history neurological disorder Chronic progressive medical condition Any history severe traumatic brain injury skull defect Metal device head , include neurostimulators metal foreign body Any implanted metal device , include pacemaker , spinal cord stimulator , VNS . Any ferromagnetic substance body ( include tattoo , dental prosthetics , etc ) . Taking medication may lower seizure threshold within 4 week prior start study , include use neuroleptic ( esp . clozapine ) , antibiotic ( penicillin , cephalosporin ) , bronchodilating medication . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>cognitive dysfunction</keyword>
	<keyword>memory loss</keyword>
	<keyword>non-invasive transcranial magnetic stimulation ( TMS )</keyword>
	<keyword>rTMS</keyword>
	<keyword>Magstim Rapid2</keyword>
</DOC>